We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Chill Brands Group Plc | CHLL | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.05 | -2.04% | 2.40 | 16:24:04 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.45 | 2.40 | 2.45 | 2.40 | 2.45 |
| Industry Sector |
|---|
| OIL & GAS PRODUCERS |
| Top Posts |
|---|
Posted at 16/5/2024 09:01 by bbmsionlypostafter mk2 Is Callum still coming back?If not maybe his mum could run CHLL. |
Posted at 11/5/2024 17:54 by institutional investments The bears rattle on about financials/fundamentAre these guys for fkn real? |
Posted at 05/5/2024 15:56 by institutional investments And tbf to chll, its not like it is not sector aligned. Actually seems to be a bit of support in the sub sector recently. hmmmmaybe funds are starting to sniff Have you looked at holdings and cashflows in the exchange traded sectors? Chll aint all that bad fundamentally at all, on comparison tables Interesting timing for here and all the news, given sector stability getting some input now? |
Posted at 28/4/2024 17:57 by judge and executioner Vlad The Impaler - 28 Apr 2024 - 16:51:02 - 8474 of 8509 Chill CBD Products - CHLLRNS & Investor News Issue of Convertible Loan Notes by ProBiotix and Related Party Transaction 14 December 2018 OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announces that further to the announcement on 24 September 2018 regarding the formation of the Company's wholly owned subsidiary ProBiotix Health Limited ("ProBiotix"), ProBiotix has raised £1.025 million of capital through the issue of convertible loan notes ("CLN"). The proceeds from the issue of CLNs will be used to provide funding for a potential initial public offering of ProBiotix. This is in line with OptiBiotix's strategy announced on 5 July 2016 to form separate divisions, which could in due course become separate legal entities with the potential for a separate public listing. OptiBiotix's strategy is based on its belief that the diversity of IP and commercial relationships across its four divisions reduces shareholder risk whilst offering multiple opportunities for value enhancement. OptiBiotix plc has subscribed for £250,000 of CLNs. Steve O'Hara, a director of the Company, has subscribed for £25,000 and certain close family members of Mr. O'Hara have subscribed for £265,000. In addition, Per Rehné, a director of the Company, has subscribed for £25,000. The remaining subscribers include two institutional investors and two industry partners. The CLNs can be converted at a fifty per cent. discount to the issue price of ProBiotix shares in the event of an IPO. The CLNs carry an interest rate of 3% per annum above the Bank of England Base Rate. As of 14 December 2018, Steve O'Hara has an interest in 10,103,029 ordinary shares in the Company, representing 11.9 per cent. of the Company's issued share capital and has an interest in a further 6,099,135 ordinary shares under option. Related Party Transaction For the purposes of the issue of CLNs, the participation of Steve O'Hara and his close family members and Per Rehné is being treated as a related party transaction ("Transaction") for the purposes of Rule 13 of the AIM Rules for Companies. The directors of the Company independent of the Transaction, having consulted with the Company's nominated adviser, Cairn Financial Advisers LLP, consider the terms of the CLNs are fair and reasonable insofar as the Company's shareholders are concerned. This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. |
Posted at 22/4/2024 05:18 by purchaseatthetop CHLL had £1.95m cash at 30/9/23 after losing £1.5m in the previous six months.On 26/1/24 £1.07m of cash was raised plus turning the £1.2m loan and accrued £13k interest of J Swann into shares. So since 30/9/23 CHLL has burned the original cash of £1.95m plus £2.27m less whatever cash balance is now. At the previous cash burn rate of £1.5m per six months they should have about £2.5m left now but Swann has said that the argument is because the USA is draining the company of cash. That should be no surprise given the previous experience with Ox Distribution now renamed as a new co to hide the association. My guess is that J Swann has discovered that there is a Going Concern qualification on its way after he has pumped fortunes into the company, that the cash is now less than six months runway, that they do not have the cash to develop new pod rechargeable products and that a huge pivot is required. |
Posted at 19/4/2024 00:07 by tewkesbury Replace the two US Directors and Chill could be back over 20p to 30p imo.Posted yesterday by Ahananda on L-S-E: Alan Green Founder and CEO at Brand Communications 1h Edited #CHLL - proposed restructuring moves should reinvigorate Chill Brands Group PLC Jonathan Swann (JS) is seeking to requisition a general meeting along with 18 other shareholders (c24% of CHLL shareholders). JS has invested c£3.6m & also bought shares in the open market. The JS shareholder group (JSG) are supportive of CEO Callum Sommerton, Scott Thompson & Eric Schrader, and the action has been bought against Antonio Russo and Trevor Taylor because JSG believes these two are actively hindering the growth of the company. Although the pivot made by the Company in the past six months to focus on the UK market has shown good results, JSG believes the cash drain from the US side of the business is holding things back. JSG also believe that corporate governance is not a priority for this Board, and they believe that the Board is not acting in the interest of all shareholders. With the departure of Mr Russo and Mr Taylor, the market will be able to clearly see a business and board aligned for the benefit of all shareholders. |
Posted at 16/4/2024 13:55 by institutional investments Institutional Investments - 06 Feb 2024 - 16:07:19 - 7664 of 7996 Chill CBD Products - CHLLVlad The Impaler29 Jan '24 - 15:32 - 7612 of 7631 Edit 0 0 0 I think a 50:50 purchase split is excellent re SUP and CHLL CHLL for the more volatile reaction from a steady market, post event ... need sup to destabilise vlad. |
Posted at 16/4/2024 12:39 by bbmsionlypostafter mk2 LOLS!!!If it doesn't take "a rocket scientist to see what is happening" why do you think CHLL's competitors & multinational £Billion$ tobacco or FMCG companies with centuries of experience, contacts, established supply lines & distributor networks CHLL can't even begin to imagine would let CHLL, operating out of Callum's bedroom in his mums house with 11 quid in it's bank account, "to be at the top of the pack before the rest of the smoking world catches on"? Get real. |
Posted at 29/1/2024 16:05 by vlad the impaler Vlad The Impaler29 Jan '24 - 15:32 - 7612 of 7631 Edit0 0 0 I think a 50:50 purchase split is excellent re SUP and CHLL CHLL for the more volatile reaction from a steady market, post event CHLL circa 3p SUP circa 110p |
Posted at 29/1/2024 15:32 by vlad the impaler I think a 50:50 purchase split is excellent re SUP and CHLLCHLL for the more volatile reaction from a steady market, post event CHLL circa 3p SUP circa 110p |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
